Phase I/II design for selecting subgroup-specific optimal biological doses for prespecified subgroups (Q7033274)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 7978733
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Phase I/II design for selecting subgroup-specific optimal biological doses for prespecified subgroups |
scientific article; zbMATH DE number 7978733 |
Statements
Phase I/II design for selecting subgroup-specific optimal biological doses for prespecified subgroups (English)
0 references
3 February 2025
0 references
Bayesian design
0 references
immunotherapy
0 references
optimal biological dose
0 references
spike and slab
0 references
subgroups
0 references
0 references
0 references
0 references
0 references
